NEW YORK (TheStreet) -- CHANGE IN RATINGS
Carefusion (CFN) was downgraded at Goldman to sell from neutral. Valuation call, based on a $36 price target.
Catamaran (CTRX) was downgraded at Goldman Sachs to neutral from buy. Company was also cut from the Conviction List. $50 price target. Valuation call, based on a lower growth outlook, Goldman said.
Finish Line (FINL) was upgraded at Bank of America/Merrill Lynch to buy from underperform. $30 price target. Pipeline is improving and Macy's deal should help drive growth, BofA/Merrill said.
[Read:Salmon: T-Mobile's Self-Defeating Resurgence]
Medtronic (MDT) - Get Report was upgraded at Goldman Sachs to buy. $66 price target. Organic growth should accelerate over the next several quarters, Goldman said.
Midcoast Energy Partners (MEP) was initiated at UBS with a buy rating. Pure play on Enbridge Energy Partners' G&P assets, UBS said. $23 price target.
[Read:Companies Cut Off Employees' Ideas? Workers Think So]
Stock Comments / EPS Changes
Westport Innovations (WPRT) - Get Report price target, EPS estimates were lowered at Jefferies. Bumps in the road driven by likely low order trends and challenging environment to execute, Jefferies said. $28 price target and buy rating.
Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of TheStreet.